Gastrointestinal Diseases
144
23
29
74
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
16 trials with published results (11%)
Research Maturity
74 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.9%
7 terminated out of 144 trials
91.4%
+4.9% vs benchmark
9%
13 trials in Phase 3/4
22%
16 of 74 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 74 completed trials
Clinical Trials (144)
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Adding a Gastrointestinal Subscore to SOFA2 for Mortality Risk Assessment in the ICU: The SOFA2-GIS Study
Evaluation of Patients With Gastrointestinal Disease
Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.
Trans-nasal Endoscopy for Bariatric Patients
Saudi Emergency Laparotomy Audit
Foregut Leaks-Role of Microbiome
Virtual Reality for Non-cardiac Chest Pain
An Observational Study of Patients With Chronic Gastrointestinal Disease
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Objective Vascular Biomarkers as Triage for Depression in Chronic Atrophic Gastritis
Enhanced Ward Rounds and Communication for Pre-procedural Anxiety in GI Endoscopy Patients
Improved Gut Health Outcomes Associated With Probiotics Fortified With Hydrolyzed Whey Protein in Infant Formula
Spatiotemporal Dynamics and Prognostic Value of the 18F-FDG PET Neuro-Metabolic Network
Gastrointestinal Myoelectric Activity Protocol, the G-Tech EEnG Protocol
Canadian Beach Cohort Study
Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in Canada